• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE Back to Search Results
Model Number N/A
Device Problem Inaccurate Delivery (2339)
Patient Problem Hypoglycemia (1912)
Event Type  Injury  
Event Description
Event verbatim [preferred term] (related symptoms if any separated by commas).Hypoglycemic crisis [hypoglycaemia].Cannot disassemble the pen [device malfunction].Case description: this serious spontaneous case from brazil was reported by a consumer as "hypoglycemic crisis(hypoglycemia)" with an unspecified onset date, "cannot disassemble the pen(device malfunction)" with an unspecified onset date, and concerned a male patient who was treated with novopen 4 (insulin delivery device) from unknown start date for "device therapy", , fiasp (insulin aspart) (dose, frequency & route used-unk) from unknown start date for "drug use for unknown indication", novolin n (insulin human) (dose, frequency & route used-unk) from unknown start date for "drug use for unknown indication".Patient's height, weight and body mass index (bmi) were not reported.Medical history was not provided.Concomitant products included - pantoprazole, xarelto(rivaroxaban), metformin.On an unknown day, the patient had a hypoglycemic crisis and the patient's daughter set up the pen to perform the application, and could not disassemble the pen.It was informed that the hypoglycemic crisis had no relation with the medications the flowtest was successfully performed.Batch number of novopen 4, fiasp and novolin n has been requested.Action taken of novpen 4 was not reported.Action taken to fiasp was not reported.Action taken to novolin n was not reported.The outcome for the event "hypoglycemic crisis(hypoglycemia)" was not reported.The outcome for the event "cannot disassemble the pen(device malfunction)" was not reported.
 
Event Description
Case description: investigation results.Name novopen 4 batch number:unknown.No investigation was possible, because neither sample nor batch number was available.Fiasp® - batch unknown.No investigation was possible, because neither sample nor batch number was available.Novolin® n - batch unknown.No investigation was possible, because neither sample nor batch number was available.Since last submission the case has been updated with the follwing: -imdrf codes added.-investigation result added.-narrative updated accordingly.Final manufacturer's comment: 17-mar-2023: the suspected device (novopen 4) has not been returned to novo nordisk a/s for the investigation.Batch number of device is not available, no batch trend analysis or reference sample analysis performed.No confounding factors identified.With the available limited information regarding the handling of the suspected device, it is not possible to identify a clear root cause in relation to functionality of novopen 4.Events are listed.This single case report is not considered to change the current knowledge of the safety profile of fiasp and novolin n.H3 continued: evaluation summary.Novopen® 4 - batch unknown.No investigation was possible, because neither sample nor batch number was available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOPEN 4
Type of Device
INSULIN DELIVERY DEVICE
Manufacturer (Section D)
NOVO NORDISK A/S, MEDICAL SYSTEMS
hilleroed,,
DA 
Manufacturer (Section G)
NOVO NORDISK A/S, MEDICAL SYSTEMS
brennum park
hilleroed,, 3400
DA   3400
Manufacturer Contact
p.o. box 846
plainsboro,, NJ 08536
8007276500
MDR Report Key16213028
MDR Text Key307767045
Report Number9681821-2023-00013
Device Sequence Number1
Product Code FMF
Combination Product (y/n)Y
Reporter Country CodeBR
PMA/PMN Number
20-986
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 01/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberN/A
Device Catalogue Number185490
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received03/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
METFORMIN (METFORMIN).; PANTOPRAZOLE (PANTOPRAZOLE).; XARELTO (RIVAROXABAN).
Patient Outcome(s) Other;
Patient SexMale
-
-